Colon Cancer
IL-11-receptor alpha-protein expression decreased in colon carcinoma
Published in Blood Weekly, October 5th, 2006
"Interleukin-11 (IL-11) has been evaluated as an anti-inflammatory and mucosa-protective therapeutic agent in inflammatory bowel diseases (IBDs). Activity of IL-11 requires binding to the alpha receptor subunit (IL-11R alpha) that provides ligand specificity," investigators in Germany report.
According to the authors, "Recently, we showed that in the intestinal mucosa, IL-11R alpha is mainly present on epithelial cells mediating antiapoptotic effects. The aim of this study was to investigate the expression profiling of IL-11R alpha...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-10-05)
More Articles from Blood Weekly
- Blood Safety
Pall System to detect bacteria in red blood cells granted CE Mark - Blood Safety
Safety concerns over the Canadian blood supply drives patients to autodonate - Blood Safety
Simian foamy virus infection occurred by whole-blood transfer in rhesus macaques - Tissue Engineering
Porous micro-patterned scaffold developed for vascular tissue engineering - Tissue Engineering
Tissue-engineered tooth produced by embryonic tooth germ cells in 3-dimensional scaffold - Alzheimer Disease
Selective Alzheimer Disease Indicator-1 gene abundantly expressed by stem cells - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
